Rigel Pharmaceuticals
RIGL
#6718
Rank
NZ$0.82 B
Marketcap
$46.77
Share price
0.70%
Change (1 day)
243.91%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): -$0.37

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.38. In 2022 the company made an earnings per share (EPS) of -$0.58 a decrease over its 2021 EPS that were of -$0.17.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.37-36.33%
2022-$0.58240%
2021-$0.17-37.5%
2020-$0.27-60%
2019-$0.68-11.11%
2018-$0.77-26.23%
2017-$1.04-17.57%
2016-$1.2625.42%
2015-$1.01-42.72%
2014-$1.761.98%
2013-$1.72-24.06%
2012-$2.27-4.32%
2011-$2.37-290.41%
2010$1.25-126.64%
2009-$4.67-25.14%
2008-$6.2441.86%
2007-$4.4070.86%
2006-$2.58-27.4%
2005-$3.55-33.33%
2004-$5.32-37.73%
2003-$8.55-31.83%
2002-$12.54-63.55%
2001-$34.40-96.43%
2000-$964.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.22 759.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.46 554.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.39-1,002.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
$24.14-6,531.82%๐Ÿ‡บ๐Ÿ‡ธ USA